Quantcast

Latest ACell Stories

2014-07-15 08:29:38

COLUMBIA, Md., July 15, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced enrollment of the first patient in a U.S. Phase IV clinical trial (NCT02021279; www.clinicaltrials.gov) evaluating the safety and long-term effectiveness of ACell's MatriStem® Pelvic Floor Matrix device as compared to native tissue repair for the treatment of pelvic organ prolapse....

2014-05-30 16:24:52

SARASOTA, Fla., May 30, 2014 /PRNewswire-iReach/ -- On Friday, April 18(th) PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc. Orogen, based out of Sarasota, Florida, was an early innovator in processing platelet rich plasma (PRP) and concentrating growth factors, cytokines, proteins and adhesion molecules to optimize the most effective and efficient methods for...

2014-03-31 08:30:30

New contract broadens access of MatriStem to an additional 100,000 healthcare entities COLUMBIA, Md., March 31, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has entered into a national purchasing agreement with Novation for the Company's MatriStem® devices. The MatriStem devices also were awarded the elite Innovative Technology...

2014-03-26 08:29:41

CME-credited Event to Leverage Broad UBM Clinical Experience for Expanded Awareness COLUMBIA, Md., March 26, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it will sponsor a continuing medical education (CME) credited lecture at the upcoming Academy of Physicians in Wound Healing (APWH) 2014 Annual Conference taking place March 27-30 in...

2014-02-10 08:27:05

Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb. 10, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has launched the new MatriStem® Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds. The one-to-one (1:1) mesh design of MatriStem Multilayer Wound Matrix is built to...

2014-02-05 08:29:47

Offers broad range of regenerative therapy solutions COLUMBIA, Md., Feb. 5, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has expanded the MatriStem® Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating...

2014-01-13 08:29:02

COLUMBIA, Md., Jan. 13, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced it has initiated, with multiple patients enrolled, a U.S. post-market clinical trial (NCT01858545) comparing the efficacy of MatriStem® to a leading cellular scaffold, Dermagraft®, for the treatment of patients with diabetic foot ulcers (DFUs) that failed to adequately heal...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'